Skip to Content

3138 WPI (Nizatidine 300 mg)

Pill with imprint 3138 WPI is Brown, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; indigestion; duodenal ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3138 WPI

Nizatidine 300 mg 3138 WPI

Nizatidine

Imprint
3138 WPI
Strength
300 mg
Color
Brown
Size
22.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3138
Inactive Ingredients
silicon dioxide, corn starch, croscarmellose sodium, magnesium stearate, ammonia, ferrosoferric oxide, gelatin, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, titanium dioxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.